M
$ Value
$6.9M
Shares
84,360
Price
$82
Filed
Feb 2
Insider
Name
HAZEN SAMUEL N
Title
CEO
CIK
0001216838
Roles
Director
Officer
Transaction Details
Transaction Date
2026-01-30
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
116,636
Footnotes
The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027. | The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
Filing Info
HAZEN SAMUEL N's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | HCA | A | $0 |
| 2026-02-10 | HCA | F | $10.7M |
| 2026-02-04 | HCA | J | $521K |
| 2026-02-04 | HCA | J | $521K |
| 2026-02-03 | HCA | ▼ | $7.4M |
| 2026-02-03 | HCA | ▼ | $2.5M |
| 2026-02-03 | HCA | ▼ | $3.7M |
| 2026-02-03 | HCA | ▼ | $3.1M |
| 2026-02-03 | HCA | ▼ | $2.6M |
| 2026-02-03 | HCA | ▼ | $2.1M |
Other Insiders at HCA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FRIST THOMAS F JR | — | — | 2026-02-06 |
|
HAZEN SAMUEL N
CEO
|
— | $21.5M | 2026-02-10 |
| FRIST THOMAS F III | — | — | 2026-02-06 |
| HERCULES HOLDING II | — | — | 2026-02-06 |
| Frisco Holding II | — | — | 2026-02-06 |
| Elcan Patricia F | — | — | 2026-02-06 |
| Frist William R | — | — | 2026-02-06 |
|
Foster Jon M
EVP and COO
|
— | — | 2026-02-10 |
|
Cuffe Michael S.
EVP and Chief Clinical Officer
|
— | $747K | 2026-02-10 |
|
Wyatt Christopher F.
SVP & Controller
|
— | $2.0M | 2026-02-11 |
|
Berres Jennifer
SVP & Chief Human Res. Officer
|
— | $4.1M | 2026-02-11 |
|
McAlevey Michael R
EVP & Chief Legal & Admin Off.
|
— | $904K | 2026-02-18 |
|
Marks Mike A
EVP and CFO
|
— | — | 2026-02-10 |
|
Rossitto Erica
SVP & Chief Nurse Executive
|
— | — | 2026-02-10 |